Bluemoor Health reports quarterly revenue above the internal plan
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
Bluemoor Health
Healthcare · Medical Devices
Updated UTC
146,21 US$
+1,91+1,32 %
After hours145,56 US$-0,44 %
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 12,63 mil M | 14,13 mil M | 15,19 mil M | 15,96 mil M | 17,26 mil M |
| Gross profit | 7233,39 M | 8427,66 M | 8678,83 M | 9276,92 M | 10,31 mil M |
| Operating income | 2623,05 M | 3117 M | 3200,42 M | 2987,01 M | 3136,37 M |
| Net income | 1865,77 M | 1818,78 M | 2377,79 M | 2031,32 M | 2489,26 M |
Develops remote-monitoring hardware and clinical software for chronic-care providers.
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
The company approved a multi-year capital program intended to shorten lead times for its largest customers.
Market Wire
A sell-side desk kept a neutral rating while noting that near-term estimates already reflect steady execution.
Sector Desk
The board named an internal candidate with prior treasury and investor-relations experience to the role.
Market Wire
The authorization covers a modest slice of the float and will be funded from operating cash flow.
Market Wire